{"id":"W4224035803","doi":"10.1158/1078-0432.ccr-21-3807","title":"Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme","keywords":"Pembrolizumab; Phases of clinical research; Clinical trial; Adverse effect; Immunotherapy; Expanded access; Hepatocellular cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006213373,0.0003745884,0.001068672,0.0001219485,0.001879598,0.0001781933,0.002868702,0.0002058223,0.003110961],"category_scores_gemma":[0.001103461,0.0002690317,0.0002737074,0.0007973727,0.0004241917,0.0002364306,0.00292378,0.001573199,0.00003896788],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004921134,"about_ca_system_score_gemma":0.002391391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003821052,"about_ca_topic_score_gemma":0.0002046938,"domain_scores_codex":[0.9927829,0.001984028,0.001177812,0.001664507,0.001318898,0.001071846],"domain_scores_gemma":[0.9924941,0.003368499,0.0002455998,0.002963482,0.0004178553,0.0005104418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5800749,0.01222956,0.1692875,0.00007543428,0.001094535,0.0004359724,0.0005994203,0.000001861645,0.001028321,0.000128933,0.09177833,0.1432652],"study_design_scores_gemma":[0.4841991,0.03601209,0.0008997753,0.00008170025,0.0006141944,0.000008771477,0.0002374031,0.02720053,0.0009221694,0.00053372,0.4488819,0.0004086112],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9592515,0.0143206,0.00006016175,0.009627426,0.0006901874,0.01331323,0.002364239,0.00007835744,0.0002943469],"genre_scores_gemma":[0.9796154,0.001871478,0.0005160688,0.001100377,0.001523502,0.008233104,0.003777547,0.0001326394,0.003229918],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3571036,"threshold_uncertainty_score":0.9999762,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6690422892842558,"score_gpt":0.5552228490778292,"score_spread":0.1138194402064266,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}